Concepedia

Natacha Bordry

NB

Statistics

Publications

9

Citations

1.1K

H-Index

9

Active since

2014

Affiliations

Ludwig Cancer Research(Current)

University of Lausanne

École Polytechnique Fédérale de Lausanne

University of Chicago

Hôpital Orthopédique de la Suisse Romande

Natacha Bordry is an author at Ludwig Cancer Research specializing in oncology, immunology, and tumor immunology.

ORCID

Publications per year

2014–2022

9

Publications

9

T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

Natalie J. Neubert, Martina Schmittnaegel, Natacha Bordry et al. · Science Translational Medicine · 2018 · 296 citations · Full text

, , +17

Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma

Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin et al. · Science Translational Medicine · 2017 · 246 citations · Full text

, , +14

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer

Alfredo Addeo, Pankil Shah, Natacha Bordry et al. · Cancer Cell · 2021 · 243 citations · Full text

, , +12

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

Maria A.S. Broggi, Léa Maillat, Cristina C. Clement et al. · The Journal of Experimental Medicine · 2019 · 140 citations · Full text

, , +17

Very Late Antigen-1 Marks Functional Tumor-Resident CD8 T Cells and Correlates with Survival of Melanoma Patients

T. J. Murray, Silvia A. Fuertes Marraco, Petra Baumgaertner et al. · Frontiers in Immunology · 2016 · 101 citations · Full text

, , +17

1–5 of 9